Biolink Group

What Biolink Group does

Biolink Group AS is a privately-held Norwegian holding company headquartered at Hanabryggene Technology Centre in Sandnes, Norway, that develops biological applications based on anthocyanins. Founded in March 1999 and tracing its origins to a 1998 joint venture with the University of Bergen, the group operates through wholly-owned subsidiaries spanning the anthocyanin value chain: Polyphenols AS supplies over 30–36 pure polyphenol products (anthocyanins, anthocyanidins, stilbenes, flavonols) with HPLC purity above 97% to research and industry customers; Biosynth AS runs a patented worldwide organic synthesis process for anthocyanins and is described as the only company producing synthetic anthocyanins at scale; Medpalett AS produces the Medox® and Healthberry® nutraceutical brands from wild bilberry and blackcurrant extracts; Diagnostrix AS is developing a diagnostic system for endometriosis; BreedSENSE AS is commercializing a smart breeding system for cattle; and Imuxol AS is a newer startup established in 2023. Core technology combines natural extraction of polyphenols with proprietary organic synthesis of anthocyanin molecules, including BSC 3G (Cyanidin 3-glucoside) and BSD 3G (Delphinidin 3-glucoside). The platform is applied across nutraceuticals, research reagents, functional food ingredients, diagnostics, and agriculture.

The group's commercial model is dual-track. B2B revenue comes from quote-based direct sales of pure polyphenols and synthetic anthocyanins to universities, university hospitals, pharmaceutical companies, food and wine companies, and chemical/biological laboratories globally, with Polyphenols shipping to more than 60 countries and serving 600+ R&D groups. Consumer-facing revenue runs through Medpalett's Medox® dietary supplement brand, which has held the leading dietary supplement position in Norway since 2012 and cumulatively sold over 300 million capsules by 2025; Medpalett was reacquired from Evonik in 2025 after a 2016 divestiture. Production capacity includes modern laboratories and a 2021 pilot production plant at Foss Eikeland. The company is controlled by its founders (including Sjur Svaboe and Kristian Larsen), has 1–10 reported employees at the holding level, and has not disclosed funding rounds, valuation, or revenue figures.

Name

Biolink Group

Legal name

Biolink Group AS

Website

https://biolink.no

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

1–10 employees

Short description

Biolink Group AS is a Norwegian holding company that develops anthocyanin-based products through subsidiaries spanning nutraceuticals (Medox®), pure polyphenol ingredients, patented organic synthesis, endometriosis diagnostics, and agricultural technology, serving pharmaceutical and research customers in 60+ countries.

Ownership category

akta.pro rank

Product category

Nutraceuticals and Polyphenol Ingredients

NAICS

Medicinal and Botanical Manufacturing (325411), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Medicinal Chemicals & Botanical Products (2833), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF)

akta.pro secondary industries

Raw Materials & Critical Reagents Supply Services (media, resins, single-use) (HLAAAKAI), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK), Probiotics & Digestive Health Supplements (CRADAGAF)

Keywords

• Anthocyanin extraction
• Polyphenol ingredients
• Nutraceutical supplements
• Anthocyanin synthesis
• Diagnostic systems

Headquarters

HQ city

Sandnes

HQ country

Norway

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Nutraceutical Products (Medox® & Healthberry®): Sale of premium anthocyanin-based dietary supplements through Medpalett. Medox® contains concentrated extracts from wild bilberries and blackcurrants. Healthberry® is a highly concentrated powder extract with 17 unique natural anthocyanins.
2. Pure Polyphenols B2B Sales: Sale of pure anthocyanins, anthocyanidins, stilbenes, and flavonols to universities, hospitals, pharma companies, and industries worldwide. Products delivered with HPLC purity above 97%.
3. Diagnostic Systems: Diagnostic system for endometriosis developed by Diagnostrix AS subsidiary.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Biolink Group is a life science holding company that develops, produces, and commercializes anthocyanin-based products through its subsidiaries. Its core offerings include pure polyphenol ingredients (anthocyanins, anthocyanidins, stilbenes, flavonols with HPLC purity above 97%) sold B2B to universities, hospitals, and pharmaceutical companies, and the Medox® and Healthberry® nutraceutical brands sold B2C in Norway. The company also holds a worldwide patent for organic synthesis of anthocyanins and operates a diagnostic system subsidiary (Diagnostrix) for endometriosis.

Product overview

Biolink Group is a holding company focused on anthocyanins-based biotechnology R&D within Life Science and Sustainable Environment. The group operates through several subsidiaries: Medpalett AS produces Medox and Healthberry nutraceutical products from bilberry and blackcurrant extracts; Polyphenols AS supplies over 30 pure polyphenol products to researchers and pharma companies worldwide; Biosynth AS produces synthetic anthocyanins at scale; Diagnostrix AS offers diagnostic systems for endometriosis; and BreedSENSE AS provides smart breeding systems for cattle. The company was founded in 1999 and has been working in biotech R&D since the early 1980s.

Differentiator

Problem solved

Functional benefit

Brands

• Medox®: Premium nutraceutical product - concentrated extracts from wild bilberries and blackcurrants rich in anthocyanins. Developed and manufactured in Norway.
• Healthberry®

Products and services

• Medox® Premium nutraceutical supplement developed and manufactured in Norway, containing concentrated extracts from wild bilberries and blackcurrants rich in anthocyanins. Each capsule delivers powerful antioxidants for health benefits, targeted at health-conscious consumers in Norway.
• Healthberry® Highly concentrated powder extract made from anthocyanin-rich berries (wild bilberries and blackcurrants), containing 17 unique natural anthocyanins. Developed as a versatile foundation for various applications, targeted at health-conscious consumers and as a functional food ingredient.
• Polyphenols Products Portfolio of more than 30 pure polyphenol products including anthocyanins, anthocyanidins, stilbenes and flavonols extracted from natural sources. Products include Pelargonidin, Cyanidin, Peonidin, Delphinidin, Petunidin, and Malvidin derivatives, all delivered with HPLC purity above 97%, sold to universities, university hospitals, pharmaceutical companies, food and beverage manufacturers, and medical/chemical/biological laboratories worldwide.
• Biosynth Synthetic Anthocyanins (BSC 3G and BSD 3G) Organic synthetic production of anthocyanins at scale, protected by a worldwide patent. Biosynth is the only company in the world producing synthetic anthocyanins in larger quantities based on organic synthesis. Includes molecules BSC 3G (Cyanidin 3-glucoside) and BSD 3G (Delphinidin 3-glucoside) intended for medical applications including cardiovascular and ophthalmology research, sold to pharmaceutical companies and researchers.
• Diagnostrix Endometriosis Diagnostic System Diagnostic system for endometriosis developed by the Diagnostrix AS subsidiary, targeted at medical professionals and healthcare providers seeking non-invasive diagnostic solutions.

Quantifiable outcome

• 300+ million Medox capsules sold by 2025
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• University of BergencoreStrategic or Co-development Partner · 1 January 1998Cooperation initiated in 1998 based on extraction technology for pure polyphenols and flavonoids. A joint venture was established resulting in Polyphenols AS. Scientists from University of Bergen mapped main chemical structures of flavonoids (~4000 compounds) and identified anthocyanins as having significant biological potential.
• Pharmaceutical CompaniescoreStrategic or Co-development PartnerOngoing research collaborations with pharmaceutical companies. Biolink Group supports medical studies with anthocyanins and knowledge. Studies have been published in well-reputed international publications.
• Various UniversitiescoreStrategic or Co-development PartnerBiolink Group contributes to research society by offering PhD and Master students ability to do research within the group. Students work at company laboratories and do formal fields of study at collaborating universities. Many students have benefited from cooperation over the years.

Scale indicators7 records

Recent moves14 records

Expansion highlights5 records

Broad incumbents

• Sabinsa: US-headquartered ingredient manufacturer specializing in standardized botanical extracts and nutraceutical actives. Comparable to Biolink/Medpalett's Medox business in supplying branded polyphenol and antioxidant ingredients to supplement formulators globally.
• Givaudan (Natural Ingredients / Naturex): Swiss global flavors and natural ingredients major, having acquired Naturex. Comparable to Biolink in supplying fruit, vegetable, and botanical extracts (including anthocyanins) to food, beverage, nutraceutical, and personal care customers at industrial scale.
• Indena SpA: Italian global leader in botanical active ingredients for pharmaceutical, nutraceutical, and personal care markets. Comparable to Biolink in producing standardized polyphenol and anthocyanin extracts, but at much larger scale and broader portfolio.
• Evolva (now part of Amyris): Synthetic biology company developing fermented/yeast-produced versions of high-value ingredients (including resveratrol and other polyphenols). Comparable to Biolink's Biosynth subsidiary in using biological/synthetic routes to produce standardized polyphenol molecules at scale.

Others

• Evonik: German specialty chemicals company that previously owned Medpalett (2016-2025) and continues to operate in life science ingredients including nutraceuticals and pharmaceutical excipients. Relevant as the prior strategic owner of Biolink's consumer arm and a scaled reference customer/supplier in the same ingredient space.

Regional players

• Chr. Hansen: Danish bioscience company developing natural ingredient solutions for food, health, and agriculture. Comparable to Biolink as a Scandinavian life science company with deep microbiological/biological R&D heritage and B2B supply of bioactives to global customers.

Direct peers

• Extrasynthese: French phytochemical company specializing in the production and supply of pure polyphenol and flavonoid reference standards, including anthocyanins. Highly comparable to Biolink's Polyphenols division, serving similar research, pharma, and analytical lab customers with high-purity botanical compounds.
• Polyphenolics (Constellation Brands): US-based producer of grape-seed and berry-derived polyphenol extracts (MegaNatural) for nutraceutical and functional food applications. Directly comparable to Biolink's extraction and supply of anthocyanin-rich polyphenol products to food, beverage, and supplement industries.
• Nektium Pharma: Spanish botanical extracts producer focused on high-purity, science-backed plant actives for nutraceutical and functional food applications. Comparable to Biolink in combining proprietary extraction technology, R&D-driven product development, and B2B supply to supplement brands.
• Euromed: Spanish manufacturer of standardized botanical extracts, including grape and berry-derived polyphenols, for the nutraceutical, pharmaceutical, and food industries. Directly comparable in customer base (pharma/food/cosmetics) and product category (polyphenol-rich extracts).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biolink Group